Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 5Recurrence 4Lung Neoplasms 4Hodgkin Disease 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 2Rhabdomyosarcoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Adenocarcinoma of Lung 2Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

X-Rays 1Vinorelbine 1Vincristine 1Specimen Handling 1Radiotherapy 1Radiation 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Dactinomycin 1Cyclophosphamide 1Crizotinib 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma, Alveolar × Vinorelbine × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡